BioScrip (NASDAQ: BIOS) and Amedisys Home Health and Hospice Care (NASDAQ:AMED) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, valuation, analyst recommendations, profitability, earnings, dividends and risk.
Many gold mining stocks have global footprints or have operations/exploration projects in countries that most investors would have trouble finding on a map. However, that may not be necessary as there are two good reasons to be looking atgold and domestic gold miners right now:
Donald Trump appears serious about trying to de-regulate and undo many Obama era regulations (especially on mining/natural....More>>>
Related MPEL Macau Records Largest Monthly Revenue Growth In Nearly 3 Years Is Monthly Gaming Win Data Still A Viable Trading Opportunity? Macau posts best monthly revenue growth since early 2014 (Seeking Alpha) Related WYNN Macau Records Largest Monthly Revenue Growth In Nearly 3 Years Is Monthly....More>>>
Shares of Rogers Corp. (NYSE:ROG) gained 19.9% in April 2017, according to data from S&P Global Market Intelligence.
The company reported first-quarter results on April 26, sending share prices nearly 12% higher the next day. Rogers saw 27% year-over-year sales growth and 79% higher earnings, leaving analyst estimates far behind in both cases.
It was big newswhen outstanding student loan debt surpassed credit card debt and then later exceeded $1 trillion for the first time. That shocking statistickeeps climbing, with no sign of slowing down: Americans now have more than $1.4 trillion in unpaid education debt, according to the Federal Reserve.
Meanwhile, college-bound kids and their families try to avoid going into debt by heeding....More>>>
It does not seem as if legendary value investor Seth Klarman (Trades, Portfolio), founder of the Baupost Group, is very confident about the seemingly incessant rise in U.S. stock markets. That puts him at odds with Warren Buffett (Trades, Portfolio), who seems as confident as ever in American markets.
In his recent letter, Klarman notes the markets are currently at “perilously high....More>>>
For those who think it was a mistake to bring Joseph Papa aboard to restore the sinking ship of Valeant (NYSE: VRX), I tend to disagree. The days of buying out other companies, trimming their R&D to nothing, and raising the price of their existing drugs are long over. So a new strategy had to be developed: raising R&D spending. No one single analyst has made a mention of the huge boost in....More>>>
Twitter’s executive exodus could hurt TWTR stock investors further in the coming months, potentially also denting Twitter’s chances of turning a profit in 2017. Flickr
Patrick Moorhead, a prominent voice on the tech industry couldn’t have put it better when he said that Twitter (NYSE:TWTR)has been a revolving door for executives. The list of executives who have left....More>>>
The U.S. Securities and Exchange Commission (SEC) Chair Mary Jo White, after nearly four years as the agencys head, recently announced that she intends to leave at the end of the Obama administration.
Under Whites leadership, the agency strengthened protections for investors and the markets through transformative rulemakings that addressed major issues highlighted by the financial crisis.....More>>>
On May 9, wireless technology giantQualcomm(NASDAQ:QCOM) announced a new stock repurchase program for $10 billion of the company's shares. This program, the company said, replaces a previous buyback authorization that had $1.2 billion remaining (so the net increase in Qualcomm's buyback firepower
Editor's Note: Options are a great way to "insure" your portfolio against sudden price drops. With Tom's strategy, you can make markets pay for that "insurance," cutting your risk even more. Here's Tom…
We've looked before at twoways to make money when interes
On a busy day for bank earnings, Citigroup (NYSE:C) was one of three big U.S. banks to report results, and despite an earnings beat, the report wasn't great. While the bank's efficiency was strong and loans and deposits grew, the bank missed expectations in several key areas, including trading r
Headlines about Aldeyra Therapeutics (NASDAQ:ALDX) have trended somewhat positive on Saturday, Accern Sentiment reports. Accern identifies negative and positive press coverage by monitoring more than 20 million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies
One is known as one of the first online brokers, and the other is famous for pioneering index funds, but they both help millions of people save for retirement with IRAs. In this article, we'll compare E*Trade's and Vanguard'sIRA accounts, based on factors like commissions, account fees, and inves